Caplight Directory>Investors>Medicxi>Medicxi


Medicxi

Medicxi

London, Englandmedicxi.com

Overview

Medicxi is a European investment firm focused on the life sciences sector . It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs . Medicxi invests in early and late-stage therapeutics with a product vision that can fulfil a clear unmet medical need .

Year Founded

2016

Portfolio Companies

26

Investments

CompanyDateStageLead
Altesa BiosciencesFeb 2026Series BCo-investor
D3 BioDec 2025Series BCo-investor
Fore BiotherapeuticsMay 2025Series D ExtensionLead
CurevoMar 2025Series BLead
Ottimo PharmaDec 2024Series ACo-investor
View all investments

Key People

Giuseppe Zocco

Co-Founder And Partner

Richard Lee

Co-Founder And Operating Partner

Benjamin Perry

Venture Partner

Charles Grummitt

Venture Partner

Marco Prunotto

Venture Partner

Stephen Rapecki

Venture Partner

Thibaut De Smedt

Venture Partner

Giovanni Mariggi

Partner

Giovanni Pericolini

Partner And CFO

Shyam M.

Principal

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.